• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.50% Nasdaq Up0.23%

    Hemispherx Biopharma, Inc. (HEB)

    -NYSE MKT
    0.19 Up 0.00(0.05%) 10:50AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 36   40   45   36  
    Cost of Revenue372  328  306  294  
    Gross Profit (336) (288) (261) (258)
    Operating Expenses
    Research Development2,674  2,438  1,894  2,330  
    Selling General and Administrative1,913  1,847  2,174  2,497  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (4,923) (4,573) (4,329) (5,085)
    Income from Continuing Operations
    Total Other Income/Expenses Net1,480  119  130  132  
    Earnings Before Interest And Taxes(3,443)(4,454)(4,199)(4,953)
    Interest Expense2  2  3  3  
    Income Before Tax(3,445)(4,456)(4,202)(4,956)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(3,445)(4,456)(4,202)(4,956)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (3,445) (4,456) (4,202) (4,956)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (3,445) (4,456) (4,202) (4,956)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.